03:27 PM EST - Helix BioPharma Corp. : Has entered into a collaboration agreement with Moffitt Cancer Center to extract radiomics data using their proprietary HealthMyne platform from CT scans of late stage lung cancer patients treated with L-DOS47. Helix BioPharma Corp.
shares T.HBP are trading down $0.05 at $0.90.
